Founded in 2004, Crosstree is a boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the health sciences industries: pharmaceutical services and technology, diagnostics and tools, and healthcare technology. The firm provides clients with a full suite of advisory and capital raising services, including buy-and sell-side mergers and acquisitions advisory, private capital raising, and strategic advisory and has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. All securities transactions are offered by and conducted through Crosstree Capital Securities, LLC, a broker-dealer registered with the SEC, a member of FINRA (www.finra.org) and SIPC (www.sipc.org), and an affiliate of Crosstree.